Clarity Pharmaceuticals Ltd.ASX: CU6

Ceasing to be a substantial holder

· Issued by Clarity Pharmaceuticals Ltd. via ASX

Filed with ASX · · 4 pages · English

Release

Form 605 Corporations Act Notice of ceasing to be a substantial holder Section 671B To: Clarity Pharmaceuticals Ltd (“CU6”, Ordinary Fully Paid) 1. Details of substantial shareholder Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) and each of the related bodies corporate in the...

Clarity Pharmaceuticals Ltd. on 6ix

Earlier from Clarity Pharmaceuticals

All Clarity Pharmaceuticals news releases